Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookNational Guidelines for the Clinical Management of HIV/AIDS - Tanzania (NACP; 2005; 131 pages)
View the documentLIST OF ABBREVIATIONS
View the documentACKNOWLEDGEMENTS
View the documentFOREWORD
Open this folder and view contentsCHAPTER 1: INTRODUCTION
Open this folder and view contentsCHAPTER 2: ORGANIZATION OF HIV/AIDS CARE AND TREATMENT
Open this folder and view contentsCHAPTER 3: HIV/AIDS PREVENTION
Open this folder and view contentsCHAPTER 4: PROTECTIVE MEASURES AGAINST HIV TRANSMISSION
Open this folder and view contentsCHAPTER 5: LABORATORY TESTS IN HIV/AIDS
close this folderCHAPTER 6: HIV/AIDS AND PREGNANCY
View the document6.1 Introduction
View the document6.2 Mother to Child Transmission of HIV (MTCT)
View the document6.3 Prevention of Mother to Child Transmission of HIV (PMTCT)
close this folder6.4 Antenatal care of women with HIV/AIDS
View the document6.4.1 Care during labour and delivery
View the document6.4.2 Postnatal care of a woman with HIV/AIDS
View the document6.4.3 Follow up for the HIV Exposed Child
View the document6.4.4 Use of prophylactic antiretroviral (ARV) drugs during pregnancy
Open this folder and view contentsCHAPTER 7: PEDIATRIC HIV/AIDS AND RELATED CONDITIONS
Open this folder and view contentsCHAPTER 8: COMMUNITY AND HOME BASED CARE FOR PEOPLE LIVING WITH HIV/AIDS (PLHA)
Open this folder and view contentsCHAPTER 9: COUNSELLING RELATED TO HIV-TESTING AND TREATMENT ADHERENCE
Open this folder and view contentsCHAPTER 10: MANAGEMENT OF COMMON SYMPTOMS AND OPPORTUNISTIC INFECTIONS IN HIV/AIDS
Open this folder and view contentsCHAPTER 11: MANAGEMENT OF MENTAL HEALTH PROBLEMS IN HIV/AIDS
Open this folder and view contentsCHAPTER 12: MANAGEMENT OF HIV INFECTED PATIENTS USING ANTIRETROVIRAL DRUGS
Open this folder and view contentsCHAPTER 13: ARV THERAPY IN INFANTS AND CHILDREN
Open this folder and view contentsCHAPTER 14: USE OF ARVS IN SPECIAL CIRCUMSTANCES
Open this folder and view contentsCHAPTER 15: HIV/AIDS AND NUTRITION
Open this folder and view contentsCHAPTER 16: MANAGEMENT OF ANTIRETROVIRAL MEDICINES
Open this folder and view contentsCHAPTER 17: CERTIFICATION OF HEALTHCARE FACILITIES AS CARE AND TREATMENT SITES
 

6.4.4 Use of prophylactic antiretroviral (ARV) drugs during pregnancy

Use of antiretroviral drugs has been shown to reduce the risk of transmission from mother to child. All pregnant women who are HIV positive can be prescribed Nevirapine and advised to take it when labour starts. Women who deliver at home should be advised to bring their babies for Nevirapine administration within 72 hours of delivery. A single dose of 200 mg orally is given to the mother at onset of labour combined with a single 2 mg/kg oral dose given to her infant within 72 hours after delivery.

If a pregnant woman is on ART (first- or second-line therapy) then the baby still needs to get the single dose of NVP and the mother needs counseling on breast feeding options (exclusive breast feeding or formula etc).

For initiating ART (first and second line regimens) in pregnant women, refer to Chapter 13.

Table 8: Cotrimoxazole Prophylaxis for the HIV-exposed Child

Weight

Dosage and Formulation

Below 10 kg

5 mg/kg syrup

Between 10 - 15kg

1/2 tablet single strength

Above 15kg

2 tablets single strength

to previous sectionto next section

Please provide your feedback English  |  French